Replies to post #2229 on Revance Therapeutics Inc (RVNC)

[Bickema]

A new position Monday may be a bit hasty, barring a buyout RVNC seems dead for a long time, we are talking approx 12 months until approval. I guess ER could surprise but not enough to move the needle.

I think the best situation is an all stock deal around $42-45 per share.